Clinical trial
Semaglutide 2.4mg for Low Responders After Bariatric Surgery
NCT06287307 is registered in ClinicalTrials.gov with Zuyderland Medisch Centrum as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Semaglutide 2.4mg for Low Responders After Bariatric Surgery
- Lead sponsor
- Zuyderland Medisch Centrum
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- May 31, 2024
- Completion date
- September 30, 2026
- Enrollment
- 152 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.